
Needham upgrades Boston Scientific on easing competition, growth opportunities
Investing.com -- Needham upgraded Boston Scientific Corp (NYSE:BSX) to “Buy”, saying competition from pulsed field ablation (PFA) rivals looks less intense for its key product than it was earlier feared, and citing near- and long-term upside drivers in the company’s pipeline and recent acquisitions.The firm pointed to a recent survey of heart specialists, which showed that Boston Scient ...